Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Other Non-Current Liabilities: 2009-2025

Historic Other Non-Current Liabilities for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to $6.0 million.

  • Cumberland Pharmaceuticals' Other Non-Current Liabilities fell 2.29% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year decrease of 2.29%. This contributed to the annual value of $6.3 million for FY2024, which is 2.38% down from last year.
  • Cumberland Pharmaceuticals' Other Non-Current Liabilities amounted to $6.0 million in Q3 2025, which was down 5.55% from $6.3 million recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Other Non-Current Liabilities registered a high of $11.3 million during Q1 2022, and its lowest value of $6.0 million during Q3 2025.
  • Its 3-year average for Other Non-Current Liabilities is $6.4 million, with a median of $6.5 million in 2023.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Other Non-Current Liabilities surged by 44.56% in 2022 and then tumbled by 37.38% in 2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Other Non-Current Liabilities (Quarterly) stood at $7.5 million in 2021, then grew by 1.28% to $7.6 million in 2022, then fell by 14.92% to $6.5 million in 2023, then declined by 2.38% to $6.3 million in 2024, then dropped by 2.29% to $6.0 million in 2025.
  • Its Other Non-Current Liabilities stands at $6.0 million for Q3 2025, versus $6.3 million for Q2 2025 and $6.0 million for Q1 2025.